Neurochemical Changes in Patients with Chronic Low Back Pain Detected by Proton Magnetic Resonance Spectroscopy: A Systematic Review

Overview

Journal Neuroimage Clin

Publisher Elsevier

Specialties Neurology
Radiology

Date 2016 Dec 7

PMID 27920977

Citations 26

Authors

Xianjing Zhao

Maosheng Xu

Kristen Jorgenson

Jian Kong

Affiliations

Soon will be listed here.

Abstract

Background: Low back pain is a highly prevalent health problem around the world, affecting 50% to 85% of people at some point in life. The purpose of this systematic review is to summarize the previous proton magnetic resonance spectroscopy studies on brain chemical changes in patients with chronic low back pain (CLBP).

Methods: We identified relevant studies from a literature search of PubMed and EMBASE from 1980 to March 2016. Data extraction was performed on the subjects' characteristics, MRS methods, spectral analyses, cerebral metabolites and perceptual measurements.

Results: The review identified 9 studies that met the inclusion criteria, comprised of data on 135 CLBP subjects and 137 healthy controls. Seven of these studies reported statistically different neurochemical alterations in patients with CLBP. The results showed that compared to controls, CLBP patients showed reductions of 1) -acetyl-aspartate (NAA) in the dorsolateral prefrontal cortex (DLPFC), right primary motor cortex, left somatosensory cortex (SSC), left anterior insula and anterior cingulate cortex (ACC); 2) glutamate in the ACC; 3) myo-inositol in the ACC and thalamus; 4) choline in the right SSC; and 5) glucose in the DLPFC.

Conclusion: This review provides evidence for alterations in the biochemical profile of the brain in patients with CLBP, which suggests that biochemical changes may play a significant role in the development and pathophysiology of CLBP and shed light on the development of new treatments for CLBP.

Citing Articles

Assessing the balance between excitation and inhibition in chronic pain through the aperiodic component of EEG.

Gil Avila C, May E, Bott F, Tiemann L, Hohn V, Heitmann H Elife. 2025; 13.

PMID: 39804154 PMC: 11729367. DOI: 10.7554/eLife.101727.

Chronic neuropathic pain components in whiplash-associated disorders correlate with metabolite concentrations in the anterior cingulate and dorsolateral prefrontal cortex: a consensus-driven MRS re-examination.

Pinilla-Fernandez I, Rios-Leon M, Deelchand D, Garrido L, Torres-Llacsa M, Garcia-Garcia F Front Med (Lausanne). 2024; 11:1404939.

PMID: 39156690 PMC: 11328873. DOI: 10.3389/fmed.2024.1404939.

Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study.

Shigemura T, Osone F, Hara A, Miyano K, Okada A, Yokokawa T J Neural Transm (Vienna). 2024; 131(9):1079-1094.

PMID: 38896135 DOI: 10.1007/s00702-024-02791-1.

The psychophysiology of music-based interventions and the experience of pain.

Arnold C, Bagg M, Harvey A Front Psychol. 2024; 15:1361857.

PMID: 38800683 PMC: 11122921. DOI: 10.3389/fpsyg.2024.1361857.

Current Evidence for Biological Biomarkers and Mechanisms Underlying Acute to Chronic Pain Transition across the Pediatric Age Spectrum.

Duff I, Krolick K, Mahmoud H, Chidambaran V J Clin Med. 2023; 12(16).

PMID: 37629218 PMC: 10455285. DOI: 10.3390/jcm12165176.

References

Grachev I, Ramachandran T, Thomas P, Szeverenyi N, Fredrickson B . Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. J Neural Transm (Vienna). 2003; 110(3):287-312. DOI: 10.1007/s00702-002-0781-9. View

Mouraux A, Diukova A, Lee M, Wise R, Iannetti G . A multisensory investigation of the functional significance of the "pain matrix". Neuroimage. 2010; 54(3):2237-49. DOI: 10.1016/j.neuroimage.2010.09.084. View

Yang J, Sykora P, Wilson 3rd D, Mattson M, Bohr V . The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliency. Mech Ageing Dev. 2011; 132(8-9):405-11. PMC: 3367503. DOI: 10.1016/j.mad.2011.06.005. View

ONeill J, Eberling J, Schuff N, Jagust W, Reed B, Soto G . Method to correlate 1H MRSI and 18FDG-PET. Magn Reson Med. 2000; 43(2):244-50. PMC: 1993915. DOI: 10.1002/(sici)1522-2594(200002)43:2<244::aid-mrm11>3.0.co;2-2. View

Koes B, van Tulder M, Thomas S . Diagnosis and treatment of low back pain. BMJ. 2006; 332(7555):1430-4. PMC: 1479671. DOI: 10.1136/bmj.332.7555.1430. View

Malet-Martino M, Holzgrabe U . NMR techniques in biomedical and pharmaceutical analysis. J Pharm Biomed Anal. 2011; 55(1):1-15. DOI: 10.1016/j.jpba.2010.12.023. View

Grachev I, Fredrickson B, Apkarian A . Brain chemistry reflects dual states of pain and anxiety in chronic low back pain. J Neural Transm (Vienna). 2002; 109(10):1309-34. DOI: 10.1007/s00702-002-0722-7. View

Giesecke T, Gracely R, Grant M, Nachemson A, Petzke F, Williams D . Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum. 2004; 50(2):613-23. DOI: 10.1002/art.20063. View

Glunde K, Bhujwalla Z . Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol. 2011; 38(1):26-41. PMC: 3275885. DOI: 10.1053/j.seminoncol.2010.11.001. View

10.

Apkarian A, Sosa Y, Sonty S, Levy R, Harden R, Parrish T . Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004; 24(46):10410-5. PMC: 6730296. DOI: 10.1523/JNEUROSCI.2541-04.2004. View

11.

Bustillo J, Rowland L, Mullins P, Jung R, Chen H, Qualls C . 1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry. 2009; 15(6):629-36. PMC: 2892215. DOI: 10.1038/mp.2009.121. View

12.

Janetzki L, Gussew A, Malessa R, Habenicht U, Reichenbach J, Strauss B . [Cerebral metabolic changes and chronic back pain: Study taking into consideration clinical and psychological parameters]. Schmerz. 2016; 30(2):134-40. DOI: 10.1007/s00482-015-0082-5. View

13.

Apkarian A, Bushnell M, Treede R, Zubieta J . Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005; 9(4):463-84. DOI: 10.1016/j.ejpain.2004.11.001. View

14.

Vrenken H, Barkhof F, Uitdehaag B, Castelijns J, Polman C, Pouwels P . MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med. 2005; 53(2):256-66. DOI: 10.1002/mrm.20366. View

15.

Harris R, Clauw D . Imaging central neurochemical alterations in chronic pain with proton magnetic resonance spectroscopy. Neurosci Lett. 2012; 520(2):192-6. DOI: 10.1016/j.neulet.2012.03.042. View

16.

Bulik M, Jancalek R, Vanicek J, Skoch A, Mechl M . Potential of MR spectroscopy for assessment of glioma grading. Clin Neurol Neurosurg. 2012; 115(2):146-53. DOI: 10.1016/j.clineuro.2012.11.002. View

17.

Sharma N, McCarson K, Van Dillen L, Lentz A, Khan T, Cirstea C . Primary somatosensory cortex in chronic low back pain - a H-MRS study. J Pain Res. 2011; 4:143-50. PMC: 3100229. DOI: 10.2147/JPR.S19297. View

18.

Schmidt-Wilcke T, Leinisch E, Ganssbauer S, Draganski B, Bogdahn U, Altmeppen J . Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain. 2006; 125(1-2):89-97. DOI: 10.1016/j.pain.2006.05.004. View

19.

Wand B, Parkitny L, OConnell N, Luomajoki H, McAuley J, Thacker M . Cortical changes in chronic low back pain: current state of the art and implications for clinical practice. Man Ther. 2010; 16(1):15-20. DOI: 10.1016/j.math.2010.06.008. View

20.

Soares D, Law M . Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol. 2008; 64(1):12-21. DOI: 10.1016/j.crad.2008.07.002. View